Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The Sikiric group has consistently characterized BPC-157 as resistant to degradation in human gastric juice, a property attributed to its compact 15-residue length, its five proline residues (which disrupt protease recognition motifs), and the absence of cysteine-bridgedependent tertiary structure (Sikiric et al., 2018)
It works by inhibiting the NNMT enzymea known contributor to fat storage and metabolic slowdown
Animal studies show systemic effects at lower absolute doses via injection
This gentle reconstitution prevents peptide degradation
US$ 23.40
US$ 26.39
US$ 24.75
US$ 24.52
